Considerations for the management of urgency symptoms in patients with overactive bladder syndrome
Introduction Traditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered...
Gespeichert in:
Veröffentlicht in: | World journal of urology 2009-12, Vol.27 (6), p.755-763 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 763 |
---|---|
container_issue | 6 |
container_start_page | 755 |
container_title | World journal of urology |
container_volume | 27 |
creator | Cardozo, Linda D. Van Kerrebroeck, Philip E. V. A. Staskin, David R. |
description | Introduction
Traditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered in this pivotal role.
Materials and methods
Review of published literature on this topic.
Results
The management of urgency is evolving as of major clinical importance to patients. Recent use of diary-based urgency metrics has advanced our knowledge of the presence and nature of urgency symptoms, the impact on QoL and the response to treatment options.
Conclusion
It is logical that the management of the number of urgency episodes and the degree of urgency, as well as the impact and bother associated with this core symptom are all taken into consideration along with patient interpretation to facilitate an effective outcome. |
doi_str_mv | 10.1007/s00345-009-0455-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_861590645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>861590645</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-37cc762e81a1f59eb3f3e27c3c0c188cb717c4b5642a18d89a32527a8a37f64a3</originalsourceid><addsrcrecordid>eNp1kMtqHDEQRUWIiSdOPiCbILLJquPSW1qGwXmAIZt4LdTq6nGbaWkidTvM31tmBgyBrEpQ554Sl5APDL4wAHNdAYRUHYDrQCrVyVdkw6QQnTVcvyYbMFx20llxSd7W-gDAjAb1hlwypx1YbTek3-ZUpwFLWKb2omMudLlHOocUdjhjWmge6Vp2mOKR1uN8WPJc6ZTooSXautK_03JP82NTxGV6RNrvw9CEDU5DyTO-Ixdj2Fd8f55X5O7bze_tj-721_ef26-3XRQGlk6YGI3maFlgo3LYi1EgN1FEiMza2BtmouyVljwwO1gXBFfcBBuEGbUM4op8PnkPJf9ZsS5-nmrE_T4kzGv1VjPlQEvVyE__kA95Lal9znMO3FjneIPYCYol11pw9IcyzaEcPQP_XL8_1e9b_f65fi9b5uNZvPYzDi-Jc98N4CegtlXaYXm5_H_rE-s1kOc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220278992</pqid></control><display><type>article</type><title>Considerations for the management of urgency symptoms in patients with overactive bladder syndrome</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Cardozo, Linda D. ; Van Kerrebroeck, Philip E. V. A. ; Staskin, David R.</creator><creatorcontrib>Cardozo, Linda D. ; Van Kerrebroeck, Philip E. V. A. ; Staskin, David R.</creatorcontrib><description>Introduction
Traditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered in this pivotal role.
Materials and methods
Review of published literature on this topic.
Results
The management of urgency is evolving as of major clinical importance to patients. Recent use of diary-based urgency metrics has advanced our knowledge of the presence and nature of urgency symptoms, the impact on QoL and the response to treatment options.
Conclusion
It is logical that the management of the number of urgency episodes and the degree of urgency, as well as the impact and bother associated with this core symptom are all taken into consideration along with patient interpretation to facilitate an effective outcome.</description><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-009-0455-4</identifier><identifier>PMID: 19690868</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Humans ; Medicine ; Medicine & Public Health ; Muscarinic Antagonists - therapeutic use ; Nephrology ; Oncology ; Topic Paper ; Urinary Bladder, Overactive - diagnosis ; Urinary Bladder, Overactive - drug therapy ; Urinary Bladder, Overactive - physiopathology ; Urinary Incontinence, Urge - diagnosis ; Urinary Incontinence, Urge - drug therapy ; Urinary Incontinence, Urge - physiopathology ; Urology</subject><ispartof>World journal of urology, 2009-12, Vol.27 (6), p.755-763</ispartof><rights>Springer-Verlag 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-37cc762e81a1f59eb3f3e27c3c0c188cb717c4b5642a18d89a32527a8a37f64a3</citedby><cites>FETCH-LOGICAL-c370t-37cc762e81a1f59eb3f3e27c3c0c188cb717c4b5642a18d89a32527a8a37f64a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00345-009-0455-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00345-009-0455-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19690868$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cardozo, Linda D.</creatorcontrib><creatorcontrib>Van Kerrebroeck, Philip E. V. A.</creatorcontrib><creatorcontrib>Staskin, David R.</creatorcontrib><title>Considerations for the management of urgency symptoms in patients with overactive bladder syndrome</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><addtitle>World J Urol</addtitle><description>Introduction
Traditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered in this pivotal role.
Materials and methods
Review of published literature on this topic.
Results
The management of urgency is evolving as of major clinical importance to patients. Recent use of diary-based urgency metrics has advanced our knowledge of the presence and nature of urgency symptoms, the impact on QoL and the response to treatment options.
Conclusion
It is logical that the management of the number of urgency episodes and the degree of urgency, as well as the impact and bother associated with this core symptom are all taken into consideration along with patient interpretation to facilitate an effective outcome.</description><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Muscarinic Antagonists - therapeutic use</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Topic Paper</subject><subject>Urinary Bladder, Overactive - diagnosis</subject><subject>Urinary Bladder, Overactive - drug therapy</subject><subject>Urinary Bladder, Overactive - physiopathology</subject><subject>Urinary Incontinence, Urge - diagnosis</subject><subject>Urinary Incontinence, Urge - drug therapy</subject><subject>Urinary Incontinence, Urge - physiopathology</subject><subject>Urology</subject><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kMtqHDEQRUWIiSdOPiCbILLJquPSW1qGwXmAIZt4LdTq6nGbaWkidTvM31tmBgyBrEpQ554Sl5APDL4wAHNdAYRUHYDrQCrVyVdkw6QQnTVcvyYbMFx20llxSd7W-gDAjAb1hlwypx1YbTek3-ZUpwFLWKb2omMudLlHOocUdjhjWmge6Vp2mOKR1uN8WPJc6ZTooSXautK_03JP82NTxGV6RNrvw9CEDU5DyTO-Ixdj2Fd8f55X5O7bze_tj-721_ef26-3XRQGlk6YGI3maFlgo3LYi1EgN1FEiMza2BtmouyVljwwO1gXBFfcBBuEGbUM4op8PnkPJf9ZsS5-nmrE_T4kzGv1VjPlQEvVyE__kA95Lal9znMO3FjneIPYCYol11pw9IcyzaEcPQP_XL8_1e9b_f65fi9b5uNZvPYzDi-Jc98N4CegtlXaYXm5_H_rE-s1kOc</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Cardozo, Linda D.</creator><creator>Van Kerrebroeck, Philip E. V. A.</creator><creator>Staskin, David R.</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>Considerations for the management of urgency symptoms in patients with overactive bladder syndrome</title><author>Cardozo, Linda D. ; Van Kerrebroeck, Philip E. V. A. ; Staskin, David R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-37cc762e81a1f59eb3f3e27c3c0c188cb717c4b5642a18d89a32527a8a37f64a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Muscarinic Antagonists - therapeutic use</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Topic Paper</topic><topic>Urinary Bladder, Overactive - diagnosis</topic><topic>Urinary Bladder, Overactive - drug therapy</topic><topic>Urinary Bladder, Overactive - physiopathology</topic><topic>Urinary Incontinence, Urge - diagnosis</topic><topic>Urinary Incontinence, Urge - drug therapy</topic><topic>Urinary Incontinence, Urge - physiopathology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cardozo, Linda D.</creatorcontrib><creatorcontrib>Van Kerrebroeck, Philip E. V. A.</creatorcontrib><creatorcontrib>Staskin, David R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cardozo, Linda D.</au><au>Van Kerrebroeck, Philip E. V. A.</au><au>Staskin, David R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Considerations for the management of urgency symptoms in patients with overactive bladder syndrome</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><addtitle>World J Urol</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>27</volume><issue>6</issue><spage>755</spage><epage>763</epage><pages>755-763</pages><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Introduction
Traditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered in this pivotal role.
Materials and methods
Review of published literature on this topic.
Results
The management of urgency is evolving as of major clinical importance to patients. Recent use of diary-based urgency metrics has advanced our knowledge of the presence and nature of urgency symptoms, the impact on QoL and the response to treatment options.
Conclusion
It is logical that the management of the number of urgency episodes and the degree of urgency, as well as the impact and bother associated with this core symptom are all taken into consideration along with patient interpretation to facilitate an effective outcome.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>19690868</pmid><doi>10.1007/s00345-009-0455-4</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-4983 |
ispartof | World journal of urology, 2009-12, Vol.27 (6), p.755-763 |
issn | 0724-4983 1433-8726 |
language | eng |
recordid | cdi_proquest_miscellaneous_861590645 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Humans Medicine Medicine & Public Health Muscarinic Antagonists - therapeutic use Nephrology Oncology Topic Paper Urinary Bladder, Overactive - diagnosis Urinary Bladder, Overactive - drug therapy Urinary Bladder, Overactive - physiopathology Urinary Incontinence, Urge - diagnosis Urinary Incontinence, Urge - drug therapy Urinary Incontinence, Urge - physiopathology Urology |
title | Considerations for the management of urgency symptoms in patients with overactive bladder syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T17%3A39%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Considerations%20for%20the%20management%20of%20urgency%20symptoms%20in%20patients%20with%20overactive%20bladder%20syndrome&rft.jtitle=World%20journal%20of%20urology&rft.au=Cardozo,%20Linda%20D.&rft.date=2009-12-01&rft.volume=27&rft.issue=6&rft.spage=755&rft.epage=763&rft.pages=755-763&rft.issn=0724-4983&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-009-0455-4&rft_dat=%3Cproquest_cross%3E861590645%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220278992&rft_id=info:pmid/19690868&rfr_iscdi=true |